{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:19:21Z","timestamp":1787552361225,"version":"build-2736575974"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Oral submucous fibrosis (OSF) is a chronic, potentially malignant oral mucosal disease driven by areca nut chewing. It is characterized by progressive collagen deposition and debilitating symptoms such as trismus and burning sensation, which severely impair quality of life and confer a risk of malignant transformation. Given the limited efficacy of current therapies, this review aims to provide a comprehensive and critical appraisal of the evolving therapeutic landscape for OSF. We summarize conventional strategies, including pharmacological, surgical and physical approaches, alongside emerging therapeutic strategies, through a comprehensive literature review and screening of historical periodicals. The analysis reveals that established treatments have inherent limitations, whereas emerging approaches, including biomaterial-based delivery systems, nucleic acid and cell-based therapies, drug-loaded microneedle patches, and preventive interventions, show promise by overcoming poor mucosal retention, limited epithelial penetration and rapid salivary clearance. Mechanistic insights and the therapeutic potential of these strategies are discussed based on preclinical evidence. We conclude that current OSF therapies have limited efficacy, underscoring the need for innovative approaches. Emerging biomaterial-based systems and targeted drug delivery hold substantial potential, but further clinical research is essential to validate their safety and effectiveness for patient care.<\/jats:p>","DOI":"10.3389\/fcell.2026.1891450","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:28:12Z","timestamp":1787549292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomaterial-based therapeutic strategies for oral submucous fibrosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yue","family":"Su","sequence":"first","affiliation":[{"name":"Department of Stomatology, Jining Medical University","place":["Jining, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyi","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Jining Medical University","place":["Jining, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Jining Medical University","place":["Jining, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Jining Medical University","place":["Jining, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Jining Medical University","place":["Jining, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yourong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Jining Medical University","place":["Jining, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","article-title":"Engineering the next generation of cell-based therapeutics","volume":"21","author":"Bashor","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"105810","DOI":"10.1016\/j.oraloncology.2022.105810","article-title":"Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis","volume":"127","author":"Bijai","year":"2022","journal-title":"Oral Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.addr.2021.04.005","article-title":"Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms","volume":"174","author":"Birk","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408398.2023.2301427","article-title":"Development of nano-delivery systems for loaded bioactive compounds: using molecular dynamics simulations","volume":"65","author":"Chen","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1251583","DOI":"10.3389\/fbioe.2023.1251583","article-title":"Drug-loaded mucoadhesive microneedle patch for the treatment of oral submucous fibrosis","volume":"11","author":"Cheng","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.11817\/j.issn.1672-7347.2024.240226","article-title":"Pre-assembled nanospheres in mucoadhesive microneedle patch for sustained release of triamcinolone in the treatment of oral submucous fibrosis","volume":"49","author":"Cheng","year":"2024","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"key":"B8","doi-asserted-by":"publisher","first-page":"114657","DOI":"10.1016\/j.colsurfb.2025.114657","article-title":"Chitosan nanoparticles as a targeted delivery system for anti-fibrotic microRNAs for oral submucosal fibrosis treatment","volume":"252","author":"Cheng","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1186\/s12903-024-04554-6","article-title":"A study of risk factors associated with the presence of oral potentially malignant disorders: a community-based study from northeastern Thailand","volume":"24","author":"Chiewwit","year":"2024","journal-title":"BMC Oral Health"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e48155","DOI":"10.7759\/cureus.48155","article-title":"Physiotherapeutic approach in oral submucous fibrosis: a systematic review","volume":"15","author":"Chitlange","year":"2023","journal-title":"Cureus"},{"key":"B11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1002\/jcp.27418","article-title":"Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa","volume":"234","author":"Fang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jop.70009","article-title":"Co-Transfection with anti-fibrotic microRNAs for treating oral submucous fibrosis","volume":"54","author":"Fang","year":"2025","journal-title":"J. Oral Pathol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.actbio.2022.12.006","article-title":"A biomaterial-based therapy using a sodium hyaluronate\/bioglass composite hydrogel for the treatment of oral submucous fibrosis","volume":"157","author":"Guo","year":"2023","journal-title":"Acta Biomater."},{"key":"B15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1155\/2021\/9964159","article-title":"Adipose-derived stem cell-derived extracellular vesicles inhibit the fibrosis of fibrotic buccal mucosal fibroblasts via the MicroRNA-375\/FOXF1 axis","volume":"2021","author":"Han","year":"2021","journal-title":"Stem Cells Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/prd.12266","article-title":"Molecular pathways regulated by areca nut in the etiopathogenesis of oral submucous fibrosis","volume":"80","author":"Kondaiah","year":"2019","journal-title":"Periodontol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1503757","DOI":"10.3389\/fphar.2024.1503757","article-title":"Assembly of ceria-Nrf2 nanoparticles as macrophage-targeting ROS scavengers protects against myocardial infarction","volume":"15","author":"Liao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"105919","DOI":"10.1016\/j.oraloncology.2022.105919","article-title":"Oral submucous fibrosis induced by graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"130","author":"Liu","year":"2022","journal-title":"Oral Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2409087","DOI":"10.1002\/advs.202409087","article-title":"Nanotherapies based on ROS regulation in oral diseases","volume":"12","author":"Luo","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2217\/nnm-2021-0381","article-title":"Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis","volume":"17","author":"Manikkath","year":"2022","journal-title":"Nanomedicine (Lond)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/jop.70064","article-title":"Dental pulp mesenchymal stem cell-secretome gel reverse areca nut induced oral submucous fibrosis in mice: a pilot study","volume":"55","author":"Mante","year":"2025","journal-title":"J. Oral Pathol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jre.2022.09.003","article-title":"CeO2 and CeO2-based nanomaterials for photocatalytic, antioxidant and antimicrobial activities","volume":"41","author":"Matussin","year":"2023","journal-title":"J. Rare Earths"},{"key":"B24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12249-024-02787-w","article-title":"Development of epigallocatechin 3-gallate-Loaded hydrogel nanocomposites for oral submucous fibrosis","volume":"25","author":"Mehta","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"B25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1208\/s12249-025-03180-x","article-title":"Nanocubospray of epigallocatechin gallate for prevention of oral submucous fibrosis","volume":"26","author":"Mehta","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1754209","DOI":"10.3389\/fcell.2025.1754209","article-title":"Oral submucosal fibrosis: a comprehensive review on pathogenesis, diagnosis, therapeutics and computational advances","volume":"13","author":"Mokal","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00210-025-04435-x","article-title":"Cerium oxide nanoparticles attenuate hepatic failure via blocking TGF-beta\/Smads and upregulating Nrf2\/HO-1 signaling pathways in liver fibrosis rat model","volume":"399","author":"Mowaad","year":"2026","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jobcr.2025.02.002","article-title":"Dental pulp stem cells as a novel antifibrotic therapy for oral submucous fibrosis: an in vitro study","volume":"15","author":"Narvekar","year":"2025","journal-title":"J. Oral Biol. Craniofac Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12951-025-03859-0","article-title":"An oral engineered cerium-peptide composite microsphere inhibits inflammatory bowel disease and reverses chronic fibrosis","volume":"23","author":"Qiao","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"149936","DOI":"10.1016\/j.gene.2025.149936","article-title":"TRPV4-mediated mechanotransduction of matrix stiffness in the pathogenesis, progression, and malignant transformation of oral submucous fibrosis","volume":"979","author":"Raha","year":"2026","journal-title":"Gene"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/odi.15008","article-title":"Clinical aspects of oral cancer and potentially malignant disorders in south and southeast Asia","volume":"31","author":"Ranganathan","year":"2025","journal-title":"Oral Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40463-020-0399-7","article-title":"Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management","volume":"49","author":"Rao","year":"2020","journal-title":"J. Otolaryngol. Head. Neck Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"102224","DOI":"10.1016\/j.jormas.2025.102224","article-title":"Exosomes derived from human adipose mesenchymal stem cells act as a therapeutic target for oral submucous fibrosis","volume":"126","author":"Renu","year":"2025","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13770-023-00579-0","article-title":"Exosomes derived from human adipose mesenchymal stem cells inhibits fibrosis and treats oral submucous fibrosis via the miR-181a-5p\/Smad2 axis","volume":"21","author":"Shao","year":"2024","journal-title":"Tissue Eng. Regen. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41598-025-87790-2","article-title":"Novel transcripts of EMT driving the malignant transformation of oral submucous fibrosis","volume":"15","author":"Shetty","year":"2025","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3390\/ijms20122940","article-title":"Oral submucous fibrosis: a review on etiopathogenesis, diagnosis, and therapy","volume":"20","author":"Shih","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1856931","DOI":"10.3389\/fonc.2026.1856931","article-title":"Molecular and microenvironmental drivers of malignant transformation from oral potentially malignant disorders to oral squamous cell carcinoma","volume":"16","author":"Vasundra","year":"2026","journal-title":"Front. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.17305\/bb.2023.9944","article-title":"Mechanism of adipose tissue-derived stromal cell-extracellular vesicles in treating oral submucous fibrosis by blocking the TGF-beta1\/Smad3 pathway via the miR-760-3p\/IGF1R axis","volume":"24","author":"Wang","year":"2023","journal-title":"Biomol. Biomed."},{"key":"B39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13287-024-03720-5","article-title":"DPSCs regulate epithelial-T cell interactions in oral submucous fibrosis","volume":"15","author":"Wang","year":"2024","journal-title":"Stem Cell. Res. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"176353","DOI":"10.1016\/j.ejphar.2024.176353","article-title":"PDE12 disrupts mitochondrial oxidative phosphorylation and mediates mitochondrial dysfunction to induce oral mucosal epithelial barrier damage in oral submucous fibrosis","volume":"967","author":"Wei","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jds.2022.10.028","article-title":"High frequencies of vitamin B12 and folic acid deficiencies and hyperhomocysteinemia in Taiwanese Male patients with oral submucous fibrosis","volume":"18","author":"Wu","year":"2023","journal-title":"J. Dent. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1186\/s12951-024-03067-2","article-title":"Adipose-derived stem cell exosomes attenuates myofibroblast transformation via inhibiting autophagy through TGF-beta\/Smad2 axis in oral submucosal fibrosis","volume":"22","author":"Xu","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s44321-025-00256-w","article-title":"NRF2 modulates WNT signaling pathway to enhance photodynamic therapy resistance in oral leukoplakia","volume":"17","author":"Xu","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"119161","DOI":"10.1016\/j.carbpol.2022.119161","article-title":"Recent advances in polysaccharide-based self-healing hydrogels for biomedical applications","volume":"283","author":"Yang","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"B45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41368-024-00286-z","article-title":"Stromal thrombospondin 1 suppresses angiogenesis in oral submucous fibrosis","volume":"16","author":"Yang","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/odi.14235","article-title":"Prevalence of oral submucous fibrosis among areca nut chewers: a systematic review and meta-analysis","volume":"29","author":"Yuwanati","year":"2023","journal-title":"Oral Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/ijms23031637","article-title":"Molecular mechanisms of malignant transformation of oral submucous fibrosis by different betel quid constituents-does fibroblast senescence play a role?","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2306515","DOI":"10.1002\/advs.202306515","article-title":"Spatial transcriptomic and metabolomic landscapes of oral submucous fibrosis-derived oral squamous cell carcinoma and its tumor microenvironment","volume":"11","author":"Zhi","year":"2024","journal-title":"Adv. Sci. (Weinh)"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1891450\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:28:14Z","timestamp":1787549294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1891450\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":47,"alternative-id":["10.3389\/fcell.2026.1891450"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1891450","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1891450"}}